Towards effective adjuvant treatment for urothelial cancer

Lancet Oncol. 2015 Jan;16(1):9-10. doi: 10.1016/S1470-2045(14)71187-8. Epub 2014 Dec 11.

Authors

Arlene O Siefker-Radtke¹, Jianjun Gao²

Affiliations

¹ Department of Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. Electronic address: asiefker@mdanderson.org.
² Department of Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

PMID: 25498220
DOI: 10.1016/S1470-2045(14)71187-8

No abstract available

Publication types

Comment

MeSH terms

Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
Carcinoma / drug therapy*
Carcinoma / surgery*
Cystectomy*
Female
Humans
Male
Time-to-Treatment*
Urinary Bladder Neoplasms / drug therapy*
Urinary Bladder Neoplasms / surgery*
Urothelium / drug effects*
Urothelium / surgery*